Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $17,480 | 11 | 56.7% |
| Food and Beverage | $7,729 | 450 | 25.1% |
| Consulting Fee | $4,083 | 1 | 13.2% |
| Travel and Lodging | $1,381 | 10 | 4.5% |
| Education | $174.30 | 6 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $15,302 | 22 | $0 (2019) |
| Takeda Pharmaceuticals America, Inc. | $7,904 | 16 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $1,445 | 63 | $0 (2024) |
| Novo Nordisk Inc | $1,129 | 55 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $741.62 | 38 | $0 (2023) |
| ABBVIE INC. | $692.98 | 68 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $419.01 | 24 | $0 (2018) |
| Allergan, Inc. | $343.63 | 28 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $339.77 | 22 | $0 (2022) |
| PFIZER INC. | $281.91 | 21 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $99.97 | 3 | AstraZeneca Pharmaceuticals LP ($79.97) |
| 2023 | $57.78 | 3 | SANOFI-AVENTIS U.S. LLC ($32.58) |
| 2022 | $354.13 | 33 | ABBVIE INC. ($205.43) |
| 2021 | $541.74 | 45 | AbbVie Inc. ($328.21) |
| 2020 | $484.94 | 20 | Novo Nordisk Inc ($156.57) |
| 2019 | $3,488 | 16 | Takeda Pharmaceuticals U.S.A., Inc. ($2,604) |
| 2018 | $15,064 | 162 | Takeda Pharmaceuticals U.S.A., Inc. ($12,698) |
| 2017 | $10,756 | 196 | Takeda Pharmaceuticals America, Inc. ($7,904) |
All Payment Transactions
478 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: Respiratory | ||||||
| 03/21/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $20.00 | General |
| 02/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $56.87 | General |
| Category: Respiratory | ||||||
| 03/14/2023 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 01/31/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $25.20 | General |
| Category: RESPIRATORY | ||||||
| 01/04/2023 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/22/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.30 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $8.75 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.78 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.10 | General |
| Category: NEUROSCIENCE | ||||||
| 10/12/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.72 | General |
| Category: NEUROSCIENCE | ||||||
| 10/06/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.39 | General |
| Category: NEUROSCIENCE | ||||||
| 09/06/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.17 | General |
| Category: NEUROSCIENCE | ||||||
| 09/01/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $20.75 | General |
| 08/18/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.64 | General |
| Category: NEUROSCIENCE | ||||||
| 08/17/2022 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 08/03/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.61 | General |
| Category: NEUROSCIENCE | ||||||
| 07/26/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.73 | General |
| Category: NEUROSCIENCE | ||||||
| 07/19/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.25 | General |
| Category: NEUROSCIENCE | ||||||
| 07/12/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.96 | General |
| Category: NEUROSCIENCE | ||||||
| 06/24/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $10.67 | General |
| Category: NEUROSCIENCE | ||||||
| 06/22/2022 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 06/13/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.75 | General |
| Category: NEUROSCIENCE | ||||||
| 05/17/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.18 | General |
| Category: NEUROSCIENCE | ||||||
| 05/02/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.45 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 567 | 1,180 | $230,162 | $81,174 |
| 2022 | 7 | 548 | 1,106 | $137,830 | $66,986 |
| 2021 | 8 | 670 | 1,223 | $135,993 | $77,474 |
| 2020 | 13 | 900 | 1,234 | $131,633 | $59,744 |
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 221 | 674 | $165,076 | $53,919 | 32.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 58 | 79 | $27,271 | $10,166 | 37.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 17 | 17 | $9,690 | $4,804 | 49.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 35 | 35 | $8,750 | $4,216 | 48.2% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 49 | 49 | $6,517 | $3,639 | 55.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 72 | 166 | $6,308 | $1,580 | 25.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 53 | 53 | $2,597 | $1,530 | 58.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 55 | $2,805 | $541.30 | 19.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 17 | 17 | $833.00 | $490.79 | 58.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 33 | 35 | $315.00 | $285.60 | 90.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 221 | 578 | $97,009 | $47,717 | 49.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 126 | 196 | $20,736 | $9,911 | 47.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 29 | 29 | $6,468 | $3,567 | 55.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 37 | 38 | $4,066 | $2,595 | 63.8% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 78 | 177 | $5,358 | $1,681 | 31.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 39 | 40 | $1,960 | $1,088 | 55.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 18 | 48 | $2,233 | $426.76 | 19.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 202 | 511 | $77,672 | $45,901 | 59.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 149 | 289 | $28,611 | $17,021 | 59.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 48 | 48 | $10,368 | $6,138 | 59.2% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 59 | 59 | $6,313 | $3,850 | 61.0% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 85 | 178 | $5,162 | $1,690 | 32.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 34 | 45 | $3,465 | $1,354 | 39.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 62 | 62 | $3,038 | $975.88 | 32.1% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2021 | 31 | 31 | $1,364 | $543.63 | 39.9% |
About Dr. Farris Johnson, MD
Dr. Farris Johnson, MD is a Family Medicine healthcare provider based in Athens, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1487682787.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Farris Johnson, MD has received a total of $30,847 in payments from pharmaceutical and medical device companies, with $99.97 received in 2024. These payments were reported across 478 transactions from 44 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($17,480).
As a Medicare-enrolled provider, Johnson has provided services to 2,685 Medicare beneficiaries, totaling 4,743 services with total Medicare billing of $285,377. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Athens, GA
- Active Since 06/28/2006
- Last Updated 10/25/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1487682787
Products in Payments
- Trintellix (Drug) $23,115
- FARXIGA (Drug) $1,017
- VRAYLAR (Drug) $477.80
- Ozempic (Drug) $463.78
- SOLIQUA 100/33 (Biological) $272.19
- INVOKANA (Drug) $243.83
- ENTRESTO (Drug) $241.47
- Victoza (Drug) $228.00
- Xultophy 100/3.6 (Drug) $205.11
- SOLIQUA (Drug) $200.99
- Vascepa (Drug) $196.77
- XARELTO (Drug) $169.16
- BYDUREON (Drug) $158.00
- UBRELVY (Drug) $157.26
- SOLIQUA 100/33 (Drug) $152.29
- SYMBICORT (Drug) $142.45
- Saxenda (Drug) $130.69
- TRULICITY (Drug) $117.66
- JARDIANCE (Drug) $116.98
- TRADJENTA (Drug) $115.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Athens
Timothy Law, Do, DO
Family Medicine — Payments: $18,254
Dr. Henry Morris, M.d, M.D
Family Medicine — Payments: $16,624
Alvin Wilson, D.o, D.O
Family Medicine — Payments: $13,833
Dr. James Shiver, M.d, M.D
Family Medicine — Payments: $13,306
Dr. Paul Haver, M.d, M.D
Family Medicine — Payments: $11,681
Dr. Waleed Mahmoud, D.o, D.O
Family Medicine — Payments: $11,649